These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 32156776)

  • 1. IL33 Is a Key Driver of Treatment Resistance of Cancer.
    Kudo-Saito C; Miyamoto T; Imazeki H; Shoji H; Aoki K; Boku N
    Cancer Res; 2020 May; 80(10):1981-1990. PubMed ID: 32156776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL33 Promotes Colon Cancer Cell Stemness via JNK Activation and Macrophage Recruitment.
    Fang M; Li Y; Huang K; Qi S; Zhang J; Zgodzinski W; Majewski M; Wallner G; Gozdz S; Macek P; Kowalik A; Pasiarski M; Grywalska E; Vatan L; Nagarsheth N; Li W; Zhao L; Kryczek I; Wang G; Wang Z; Zou W; Wang L
    Cancer Res; 2017 May; 77(10):2735-2745. PubMed ID: 28249897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin 33 Signaling Restrains Sporadic Colon Cancer in an Interferon-γ-Dependent Manner.
    Eissmann MF; Dijkstra C; Wouters MA; Baloyan D; Mouradov D; Nguyen PM; Davalos-Salas M; Putoczki TL; Sieber OM; Mariadason JM; Ernst M; Masson F
    Cancer Immunol Res; 2018 Apr; 6(4):409-421. PubMed ID: 29463593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between interleukin‑33 and ovarian cancer.
    Liu X; Hansen DM; Timko NJ; Zhu Z; Ames A; Qin C; Nicholl MB; Bai Q; Chen X; Wakefield MR; West G; Fang Y
    Oncol Rep; 2019 Feb; 41(2):1045-1050. PubMed ID: 30535474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL‑33 enhances glioma cell migration and invasion by upregulation of MMP2 and MMP9 via the ST2-NF-κB pathway.
    Zhang JF; Wang P; Yan YJ; Li Y; Guan MW; Yu JJ; Wang XD
    Oncol Rep; 2017 Oct; 38(4):2033-2042. PubMed ID: 28849217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin‑33 expression in ovarian cancer and its possible suppression of peritoneal carcinomatosis.
    Sekiya A; Suzuki S; Tanaka A; Hattori S; Shimizu Y; Yoshikawa N; Koya Y; Kajiyama H; Kikkawa F
    Int J Oncol; 2019 Sep; 55(3):755-765. PubMed ID: 31322193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-33 Promotes REG3γ Expression in Intestinal Epithelial Cells and Regulates Gut Microbiota.
    Xiao Y; Huang X; Zhao Y; Chen F; Sun M; Yang W; Chen L; Yao S; Peniche A; Dann SM; Sun J; Golovko G; Fofanov Y; Miao Y; Liu Z; Chen D; Cong Y
    Cell Mol Gastroenterol Hepatol; 2019; 8(1):21-36. PubMed ID: 30831322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL25
    Ozaki Y; Kinowaki K; Kawabata H; Kudo-Saito C
    Am J Cancer Res; 2023; 13(10):4931-4943. PubMed ID: 37970362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity-mediated upregulation of the YAP/IL33 signaling axis promotes aggressiveness and induces an immunosuppressive tumor microenvironment in breast cancer.
    Dai JZ; Yang CC; Shueng PW; Wang YJ; Huang CS; Chao YC; Chen CH; Lin CW
    J Cell Physiol; 2023 May; 238(5):992-1005. PubMed ID: 36852589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL33 and Mast Cells-The Key Regulators of Immune Responses in Gastrointestinal Cancers?
    Eissmann MF; Buchert M; Ernst M
    Front Immunol; 2020; 11():1389. PubMed ID: 32719677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin 33 regulates gene expression in intestinal epithelial cells independently of its nuclear localization.
    He Z; Chen L; Furtado GC; Lira SA
    Cytokine; 2018 Nov; 111():146-153. PubMed ID: 30145369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of IL33 and IL35 in oral lichen planus.
    Javvadi LR; Parachuru VPB; Milne TJ; Seymour GJ; Rich AM
    Arch Dermatol Res; 2018 Jul; 310(5):431-441. PubMed ID: 29633015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD11b
    Imazeki H; Ogiwara Y; Kawamura M; Boku N; Kudo-Saito C
    J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34261702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The IL1-like cytokine IL33 and its receptor ST2 are abnormally expressed in the affected skin and visceral organs of patients with systemic sclerosis.
    Manetti M; Ibba-Manneschi L; Liakouli V; Guiducci S; Milia AF; Benelli G; Marrelli A; Conforti ML; Romano E; Giacomelli R; Matucci-Cerinic M; Cipriani P
    Ann Rheum Dis; 2010 Mar; 69(3):598-605. PubMed ID: 19778913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL‑33/ST2 pathway in a bleomycin‑induced pulmonary fibrosis model.
    Xu J; Zheng J; Song P; Zhou Y; Guan S
    Mol Med Rep; 2016 Aug; 14(2):1704-8. PubMed ID: 27358001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renoprotective effect of calycosin in high fat diet-fed/STZ injected rats: Effect on IL-33/ST2 signaling, oxidative stress and fibrosis suppression.
    Elsherbiny NM; Said E; Atef H; Zaitone SA
    Chem Biol Interact; 2020 Jan; 315():108897. PubMed ID: 31726037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ST2 Signaling in the Tumor Microenvironment.
    Chang CP; Hu MH; Hsiao YP; Wang YC
    Adv Exp Med Biol; 2020; 1240():83-93. PubMed ID: 32060890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD11b
    Kudo-Saito C; Ogiwara Y; Imazeki H; Boku N; Uemura Y; Zhang R; Kawano-Nagatsuma A; Kojima M; Ochiai A
    Am J Cancer Res; 2021; 11(11):5428-5439. PubMed ID: 34873470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin33 deficiency causes tau abnormality and neurodegeneration with Alzheimer-like symptoms in aged mice.
    Carlock C; Wu J; Shim J; Moreno-Gonzalez I; Pitcher MR; Hicks J; Suzuki A; Iwata J; Quevado J; Lou Y
    Transl Psychiatry; 2017 Jul; 7(7):e1164. PubMed ID: 28675392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL‑33 restricts invasion and adhesion of trophoblast cell line JEG3 by downregulation of integrin α4β1 and CD62L.
    Wang XH; Liu W; Fan DX; Hu WT; Li MQ; Zhu XY; Jin LP
    Mol Med Rep; 2017 Oct; 16(4):3887-3893. PubMed ID: 28765940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.